156 related articles for article (PubMed ID: 6353660)
21. [Therapy of obstructive respiratory tract diseases. Study of afonilum retard in 3,512 patients].
Eichhorn J; Perré R
Med Welt; 1982 Dec; 33(50):1834-7. PubMed ID: 6762480
[No Abstract] [Full Text] [Related]
22. Positive benefits of theophylline in a randomized, double-blind, parallel-group, placebo-controlled study of low-dose, slow-release theophylline in the treatment of COPD for 1 year.
Zhou Y; Wang X; Zeng X; Qiu R; Xie J; Liu S; Zheng J; Zhong N; Ran P
Respirology; 2006 Sep; 11(5):603-10. PubMed ID: 16916334
[TBL] [Abstract][Full Text] [Related]
23. [Serum theophylline concentrations in patients with chronic obstructive lung diseases: a comparison of 2 methods].
Voshaar T; Schweisfurth H; Schöttes C; Prinsen J; Koch HP
Pneumologie; 1990 Feb; 44 Suppl 1():283-4. PubMed ID: 2195516
[TBL] [Abstract][Full Text] [Related]
24. The tolerability of a new oral controlled release theophylline preparation in patients with obstructive airways diseases.
Nolte D; Dusik B
Br J Clin Pract Suppl; 1984; 32():18-21. PubMed ID: 6432018
[No Abstract] [Full Text] [Related]
25. [Obstructive airway diseases. Basic therapy with pure theophylline in retard form].
Pollert I
Fortschr Med; 1982 Mar; 100(12):547-50. PubMed ID: 7042500
[No Abstract] [Full Text] [Related]
26. [Effects of theophylline on lung function and sleep in patients with severe chronic obstructive pulmonary disease].
Li Y; Liu Y
Zhonghua Jie He He Hu Xi Za Zhi; 1997 Oct; 20(5):294-8. PubMed ID: 10374456
[TBL] [Abstract][Full Text] [Related]
27. A comparison of the plasma profiles of two slow-release theophylline preparations (Nuelin depot and Theo-dur) in healthy volunteers.
Talseth T; Boye NP; Bredesen JE; Kornstad S
Ann Allergy; 1981 May; 46(5):279-80. PubMed ID: 7235323
[TBL] [Abstract][Full Text] [Related]
28. [Theophylline--once or twice daily?].
Schoch C; Menz G; Virchow C
Fortschr Med; 1987 May; 105(16):319-22. PubMed ID: 3301601
[No Abstract] [Full Text] [Related]
29. Evaluation of onset of bronchodilating effect by interruption of the air flow method.
Lulling J; Delwiche JP; Prignot J
Eur J Respir Dis; 1980 Apr; 61(2):108-12. PubMed ID: 7002572
[TBL] [Abstract][Full Text] [Related]
30. Comparison of oral salbutamol and ephedrine in chronic obstructive pulmonary disease.
Kamat SR; Hoskote VR; Store SD; Sanghavi B; Sheth UK
Indian J Chest Dis Allied Sci; 1978 Apr; 20(2):54-62. PubMed ID: 363609
[No Abstract] [Full Text] [Related]
31. Plant-based formulation in the management of chronic obstructive pulmonary disease: a randomized double-blind study.
Murali PM; Rajasekaran S; Paramesh P; Krishnarajasekar OR; Vasudevan S; Nalini K; Lakshmisubramanian S; Deivanayagam CN
Respir Med; 2006 Jan; 100(1):39-45. PubMed ID: 15905081
[TBL] [Abstract][Full Text] [Related]
32. Clinical trial of rapidly dissolving theophylline tablets.
Hartnett BJ; Marlin GE; Graham G
Med J Aust; 1974 Apr; 1(14):532-5. PubMed ID: 4598678
[No Abstract] [Full Text] [Related]
33. [Long-term therapy with a retard theophylline preparation].
Keller A; Bömches B; Kandt D
Fortschr Med; 1995 May; 113(13):197-202. PubMed ID: 7782018
[TBL] [Abstract][Full Text] [Related]
34. Double-blind clinical trial of domiodol vs S-carboxymethylcysteine in chronic obstructive lung disease.
Casali L; Rampulla C; Rossi A
Int J Clin Pharmacol Ther Toxicol; 1982 Nov; 20(11):554-7. PubMed ID: 6757153
[TBL] [Abstract][Full Text] [Related]
35. A controlled study of slow-release theophylline and aminophylline in patients with chronic bronchitis.
Jenkins PF; White JP; Jariwalla AJ; Anderson G; Campbell IA
Br J Dis Chest; 1982 Jan; 76(1):57-60. PubMed ID: 7037034
[TBL] [Abstract][Full Text] [Related]
36. [Comparing the bronchodilating effects of ipratropium bromide and theophylline].
Dai L; Li X; Yang Y
Zhonghua Jie He He Hu Xi Za Zhi; 1998 Oct; 21(10):609-11. PubMed ID: 11477880
[TBL] [Abstract][Full Text] [Related]
37. [Detection of theophylline in human serum and its clinical application].
Li LS
Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi; 1984 Jun; 7(3):139-42, 190. PubMed ID: 6518923
[No Abstract] [Full Text] [Related]
38. [Therapy of obstructive respiratory tract diseases with pure theophylline retard].
Arens PJ
Med Klin Prax; 1982 Aug; 77(18):48-53, 67. PubMed ID: 6752679
[TBL] [Abstract][Full Text] [Related]
39. [Optimizing therapy with theophylline preparations in obstructive ventilation disorders. 3. Prediction of theophylline clearance with a simple pharmacokinetic method and comparison of bioavailability of various theophylline retard preparations].
Ranke C; Schmidt G; Oellerich M; Sybrecht GW
Prax Klin Pneumol; 1983 Mar; 37(3):99-108. PubMed ID: 6856564
[No Abstract] [Full Text] [Related]
40. [Determination of the serum level of theophylline in a group of patients with chronic obstructive bronchopneumopathy].
Marzo C; Gnasso P; Dericoloso A; Borrelli G; Vacca C; Cantone F
Arch Monaldi; 1981; 36(1-2):71-5. PubMed ID: 7348162
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
